Get started
Author

Kon‐Siong G. Jie

Observed names: A Jie, A. Jie, Asiong GKS Jie, Asiong Jie, Asiong K-S. Jie, Jie Asiong, Jie KS, Jie, A., Jie, Asiong, Jie, K.S.G., Jie,Kon-Siong, K S G Asiong Jie, K S G Jie, K S Jie, K. S. G. Jie, K. S. Jie, K.-S. G. Jie, K.-S. Jie, K.-S.G. Jie, K.S.-G. Jie, K.S.G. Jie, K.‐S. G. JIE, K.‐S. G. Jie, K.‐S. Jie, Kon Siong Jie, Kon-Siong G Jie, Kon-Siong G Lie, Kon-Siong G. Jie, Kon-Siong Jie, Kon-Siong Siong Jie, Kon‐Siong Jie
Observed institutions: Zuyd University of Applied Sciences, Erasmus MC, Centre Hospitalier Universitaire de Nantes, Maastricht University, Atrium Medisch Centrum Parkstad, Zuyderland Medisch Centrum, Hovon, Care and Public Health Research Institute, Erasmus University Rotterdam
ORCID: 0000-0002-7471-0094
Observed ORCID: 0000-0002-7471-0094
OpenAlex ID: A5024312792
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
2019 · Philippe Moreau, Michel Attal, et al. · The Lancet · 967
PDF
A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma
2009 · Henk M. Lokhorst, Bronno van der Holt, et al. · Blood · 276
PDF
Role of Vitamin K in Bone Metabolism
1995 · C. Vermeer, K.-S. G. Jie, et al. · Annual Review of Nutrition · 239
Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial
2019 · Pascale Notten, Arina J ten Cate-Hoek, et al. · The Lancet Haematology · 227
PDF
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial
2021 · Philippe Moreau, Cyrille Hulin, et al. · The Lancet Oncology · 182
PDF
Effect of food composition on vitamin K absorption in human volunteers
1996 · Birgit L. M. G. Gijsbers, Kon-Siong G. Jie, et al. · British Journal Of Nutrition · 176
PDF
Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies
2007 · R.S. Boersma, K.-S.G. Jie, et al. · Annals of Oncology · 145
Vitamin K Status and Bone Mass in Women With and Without Aortic Atherosclerosis: A Population-Based Study
1996 · K.-S. G. Jie, M. L. Bots, et al. · Calcified Tissue International · 142
Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial
2024 · Philippe Moreau, Cyrille Hulin, et al. · The Lancet Oncology · 132
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial
2013 · C. Scheid, P. Sonneveld, et al. · Haematologica · 127
PDF
Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme
2011 · Lieke H. van der Helm, Canan Alhan, et al. · British Journal of Haematology · 109
Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: a population-based study
1995 · Kon-Siong G. Jie, Michiel L. Bots, et al. · Atherosclerosis · 106
Vitamin K-induced changes in markers for osteoblast activity and urinary calcium loss
1993 · Marjo H. J. Knapen, Kon-Siong G. Jie, et al. · Calcified Tissue International · 104
Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis
2008 · Jasper H. Smalberg, Manon V. M. C. W. Spaander, et al. · Thrombosis and Haemostasis · 90
HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Doxorubicin, Dexamethasone (PAD) Vs VAD Followed by High-Dose Melphalan (HDM) and Maintenance with Bortezomib or Thalidomide In Patients with Newly Diagnosed Multiple Myeloma (MM)
2010 · Pieter Sonneveld, Ingo Schmidt-Wolf, et al. · Blood · 88
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)
2020 · Pieternella Johanna Lugtenburg, Peter de Nully Brown, et al. · Journal of Clinical Oncology · 81
CAVA (Ultrasound‐Accelerated Catheter‐Directed Thrombolysis on Preventing Post‐Thrombotic Syndrome) Trial: Long‐Term Follow‐Up Results
2021 · Pascale Notten, André A. E. A. de Smet, et al. · Journal of the American Heart Association · 78
Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib/thalidomide/dexamethasone in the phase 3 CASSIOPEIA study
2021 · Cyrille Hulin, Fritz Offner, et al. · Haematologica · 54
PDF
Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial
2020 · Murielle Roussel, Philippe Moreau, et al. · The Lancet Haematology · 34
Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial
2018 · Niels WCJ van de Donk, Bronno van der Holt, et al. · The Lancet Haematology · 33
PDF
Association of Successful Ultrasound-Accelerated Catheter-Directed Thrombolysis with Postthrombotic Syndrome: A Post Hoc Analysis of the CAVA Trial
2020 · Pascale Notten, Carsten W. K. P. Arnoldussen, et al. · Thrombosis and Haemostasis · 30
PDF
The relative effects of phylloquinone and menaquinone-4 on the blood coagulation factor synthesis in vitamin K-deficient rats
1993 · Monique M.C.L. Groenen-van Dooren, Berry A.M. Soute, et al. · Biochemical Pharmacology · 30
Serum Osteocalcin as a Marker for Vitamin K-Status in Pregnant Women and Their Newborn Babies
1992 · Kon-Siong G Jie, Karly Hamulyák, et al. · Thrombosis and Haemostasis · 29
Clinical impact of assessing thrombus age using magnetic resonance venography prior to catheter-directed thrombolysis
2022 · Carsten W. K. P. Arnoldussen, Pascale Notten, et al. · European Radiology · 28
PDF
Concordance of Post-consolidation Minimal Residual Disease Rates by Multiparametric Flow Cytometry and Next-generation Sequencing in CASSIOPEIA
2019 · Herve Avet-Loiseau, Marie C. Bene, et al. · Clinical Lymphoma Myeloma & Leukemia · 28
Works count: 86
Citation count: 3,862
H-index: 26
I10-index: 39
Year
Topic
Type